ENCEFA

La Maison, France

ENCEFA is a biotech company that develops modulate CD38 drugs for age-related diseases.

$250K raised

Dec 2021

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has ENCEFA raised?

ENCEFA has raised $250K in total funding. The most recent round was Seed. The last funding was announced in December 2021.

Who are ENCEFA's investors?

ENCEFA's investors include Newchip Accelerator.

Where is ENCEFA headquartered?

ENCEFA is headquartered in La Maison, France.

What does ENCEFA do?

ENCEFA is a biotech company that develops modulate CD38 drugs for age-related diseases.

What stage is ENCEFA at?

ENCEFA is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 30, 2021.

MLA

"ENCEFA — Funding & Investors." VCBacked, December 30, 2021, https://www.vcbacked.co/company/encefa. Accessed July 3, 2026.

APA

VCBacked. (2021). ENCEFA — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/encefa

Wikipedia (cite web)

{{cite web |title=ENCEFA — Funding & Investors |url=https://www.vcbacked.co/company/encefa |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 30, 2021.